ALLHAT: What has it taught us so far?
Open Access
- 28 September 2004
- journal article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 171 (7) , 719-720
- https://doi.org/10.1503/cmaj.1031010
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- ALLHAT: Setting the Record StraightAnnals of Internal Medicine, 2004
- ALLHAT, or the Soft Science of the Secondary End PointAnnals of Internal Medicine, 2003
- Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trialsThe Lancet, 2003
- Cardiovascular prevention and blood pressure reductionJournal Of Hypertension, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and ChlorthalidoneCurrent Controlled Trials in Cardiovascular Medicine, 2002
- A New Approach for Measuring Quality of Care for Women With HypertensionArchives of internal medicine (1960), 2001